Innovent Biopharmaceutical Transformation slide image

Innovent Biopharmaceutical Transformation

Global R&D Structure with Expanding Footprint Innovent R&D Led by Dr. Yongjun Liu President, Innovent Chairman of the Department of Immunology; Founding Director of the Center for Cancer Immunology Research of MD Anderson Cancer Center Global Head of Research of Sanofi 1,500 R&D employees Innovent Academy Product Development BD & global alliance management Project and Portfolio management 300+ employees Discovery engine for global FIC/BIC products 1100+ employees China & global dual clinical development Suzhou R&D center, China Shanghai R&D center, China 20+ employees Partnership with regional and global players EK 20+ employees Maryland wet lab, US Innovent Confidential Copyright©2022 Innovent 29 29
View entire presentation